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Abstract Avidin, a positively charged egg-white glycoprotein, is
a widely used tool in biotechnological applications because of its
ability to bind biotin strongly. The high pI of avidin (V10.5),
however, is a hindrance in certain applications due to non-specific
(charge-related) binding. Here we report a construction of a
series of avidin charge mutants with pIs ranging from 9.4 to 4.7.
Rational design of the avidin mutants was based on known
crystallographic data together with comparative sequence align-
ment of avidin, streptavidin and a set of avidin-related genes
which occur in the chicken genome. All charge mutants retained
the ability to bind biotin tightly according to optical biosensor
interaction analysis. In most cases, their thermal stability
characteristics were indistinguishable from those of the wild-
type avidin. Our results demonstrate that the charge properties
of avidin can be modified without disturbing the crucial biotin-
binding activity.
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1. Introduction
Avidin is a basically charged, tetrameric glycoprotein found
in the chicken egg white. Throughout the years, avidin has
become a frequently used tool in numerous biotechnological
applications, including di¡erent localization, diagnostic and
separation technologies [1]. Recently avidin has also found
its use in a⁄nity-based targeting of drugs and imaging agents
with promising results [2^5]. All these applications are gener-
ally based on the high a⁄nity (Kd V10315 M) [6] avidin has
for biotin, a low-molecular-weight vitamin, which can be
readily attached to biologically active binders and detectable
probes. This strong interaction with biotin, combined with the
exceptional stability and four biotin-binding sites of avidin
(one per subunit) has created the inherent utility and the ver-
satility of the avidin-biotin technology.
Avidin is, however, a positively charged glycoprotein (pI
V10.5) [6], which possesses eight arginine and nine lysine
residues [7]. The high pI of avidin and the presence of carbo-
hydrate residues have been a constant hindrance to its use in
some applications, due to non-speci¢c binding (mostly charge-
related) to extraneous material. For this reason streptavidin, a
non-glycosylated and neutrally charged bacterial counterpart
of avidin [8], has become the preferred choice in such appli-
cations. The preference of streptavidin over egg-white avidin
has prevailed, despite the fact that avidin is more hydrophilic,
contains more lysine residues for potential attachment of
probes, and is considerably more abundant and cheaper
than streptavidin.
In the present work, we wanted to investigate whether the
pI of avidin can be reduced using protein engineering, without
disturbing signi¢cantly the biotin-binding activity or the
stability characteristics of avidin. We used sequence compar-
ison of streptavidin [9] and recently cloned avidin-related (avr)
genes [10], together with the crystallographic structure of avi-
din [11,12] to design the changes. This approach has allowed
us to generate a series of fully functional avidin mutants with
pIs ranging from 9.4 down to 4.7. These reduced charge mu-
tants bind biotin in a manner similar to that of wild-type
avidin and also display clearly reduced non-speci¢c binding
characteristics. Therefore, this study also o¡ers new possibil-
ities for the applications of avidin-biotin technology. Prelimi-
nary results of this work were presented at the 8th European
Congress on Biotechnology, Budapest 17^21, Hungary, Au-
gust 1997, Abstracts, p. 158.
2. Materials and methods
2.1. Site-directed mutagenesis and construction of recombinant
baculoviruses
Mutagenesis of avidin cDNA [13] was accomplished by the PCR-
based megaprimer method [14] using Pfu DNA polymerase (Strata-
gene, La Jolla, CA, USA). The oligonucleotides for mutagenesis were
purchased from either KEBO Lab (Espoo, Finland) or from MedP-
robe (Oslo, Norway). After digestion with BglII and HindIII (Prom-
ega, Madison, WI, USA), the PCR fragments were subcloned into the
BamHI/HindIII digested pFastBAC1 donor vector (Gibco-BRL, Gai-
thersburg, MD, USA). The mutations were con¢rmed by double-
stranded sequencing using Sanger’s dideoxynucleotide chain termina-
tion procedure with an automated DNA sequencer (ALF, Pharmacia
Biotech). The recombinant baculoviruses were generated using the
Bac-To-Bac baculovirus expression system according to the manufac-
turer’s instructions (Gibco-BRL). The primary virus stocks were am-
pli¢ed for large-scale production of avidin mutants and the titers of
the stocks were determined by a plaque assay procedure [15].
2.2. Expression and puri¢cation of avidin mutants
Insect cells, Sf9 (ATCC CRL 1711), were maintained as a suspen-
sion culture in serum-free Sf-900 II SFM medium (Gibco-BRL) and
infected with recombinant baculoviruses at m.o.i. of 0.5^2 pfu/cell.
The infection was allowed to proceed for 24 h, after which the culture
medium was collected by centrifugation (100Ug, 22‡C, 5 min) and
replaced with fresh biotin-free medium. After the medium change, the
infection was continued for another three days. The puri¢cation of
each avidin mutant was carried out by a⁄nity chromatography using
2-iminobiotin-agarose as previously described by Airenne et al. [16].
2.3. Protein analysis
Electrophoretic analysis was carried out using 15% (w/v) SDS-
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PAGE with discontinuous bu¡er system [17]. After electrophoresis,
proteins were either stained with Coomassie brilliant blue or blotted
onto nitrocellulose membrane for immunostaining according to
Airenne et al. [16]. Isoelectric focusing was performed using polyacryl-
amide gels with pH gradient ranging from 3 to 10. An aliquot of
avidin mutants (5 Wg) together with the pI standards (Bio-Rad) was
applied to the gel, and following the run the proteins were visualized
by Coomassie staining. The quaternary status of avidin was analyzed
by FPLC on a Superose 12 column (Pharmacia) using an LKB HPLC
system. A sample (20 Wg in 100 Wl of phosphate bu¡er with 0.65 M
NaCl, pH 7.2) was applied, and chromatography was carried out at
a £ow rate of 0.5 ml/min, using the same ionic strength in the equil-
ibration and running bu¡ers. The column was calibrated using bovine
Q-globulin, BSA, avidin standard, ovalbumin, ribonuclease and cyto-
chrome c as molecular weight markers.
2.4. Interaction analysis of avidin mutants
Binding kinetics were measured using optical biosensor technology
(IASyS Manual+, A⁄nity Sensors, Cambridge, UK). The measure-
ments (Req, in arc seconds, a measure of the mass on the surface) were
carried out using either a commercial biotin cuvette (A⁄nity Sensors)
or by immobilizing 2-iminobiotin onto the carboxymethyldextran cuv-
ette using N-hydroxysuccinimide activation. Binding of various con-
centrations of avidin or avidin mutants onto 2-iminobiotin surface
was measured in a 50 mM borate bu¡er (pH 9.5) containing 1 M
NaCl at room temperature. The iminobiotin cuvettes were regenerated
with 20 mM HCl. The measurements using the biotin cuvette were
carried out using PBS with 1 M NaCl as a binding bu¡er at room
temperature. The kinetic rate constants for association (kon) and dis-
sociation (koff ) or the dissociation constant (Kd) were calculated using
the Fast Fit program package (A⁄nity Sensors).
2.5. Thermal stability of avidin mutants
Puri¢ed avidin mutants, in the presence or absence of an excess of
biotin, were combined with sample bu¡er (0.125 M Tris-HCl, pH 6.8/
4% (v/v) SDS/20% (v/v) glycerol/0.004% (v/v) bromophenol blue/10%
(v/v) 2-mercaptoethanol) and incubated at selected temperatures, be-
fore being subjected to SDS-PAGE as described by Bayer et al. [18].
The gels were stained using Coomassie brilliant blue. The stability of
the proteins was followed by dissociation of the tetramer to the mono-
meric form.
2.6. Non-speci¢c binding assay
Successive dilutions (1 Wg, 200 ng, 40 ng and 8 ng) of a DNA
sample (salmon-sperm DNA or pGEM plasmid DNA) were applied
to nitrocellulose strips. The DNA was ¢xed to the strips by UV
irradiation, after which the strips were quenched using 5U Denhardt’s
solution. The sample (20 Wg in 1 ml PBS) was then added to a strip
and incubated at room temperature for 90 min. After that, the strips
were washed with PBS/0.05% Tween 20 solution and stained immu-
nochemically as described by Airenne et al. [16].
3. Results
3.1. Design of avidin mutants
In order to reduce the positive charge of avidin, a series of
six mutants was constructed with pI range from 9.9 down to
4.7, as calculated theoretically from amino acid sequences us-
ing the GCG program package (Genetics Computer Group,
Madison, WI, USA). The alterations were done by changing
selected basic amino acids to neutral or acidic ones using site-
directed mutagenesis (Table 1) and the proteins were named
according to the actual pI. The selection of amino acids for
lowering the pI was based on sequence comparison of avidin,
streptavidin and avidin-related proteins (AVR), combined
with the available crystallographic data of avidin. All the
altered amino acids are surface residues and, according to
structural information, have no major role in biotin binding
or stability of the avidin tetramer. Where possible, we tried to
change arginine residues rather than lysines, due to the im-
portance of their terminal amino groups for derivatization of
avidin in many applications.
3.2. Expression and puri¢cation of avidin mutants
We have shown previously [16] that avidin can be produced
e⁄ciently in Sf9 insect cells, using a baculovirus expression
system. The expression of the avidin mutants was generally
comparable to that of the wild type, although some correla-
tion between production and the number of the mutations
was evident ^ AvdpI9.4 and AvdpI7.9 being best in this re-
spect (data not shown). All the mutants were puri¢ed to 95%
purity (judged from SDS-PAGE gel) in one step, using a⁄nity
chromatography with 2-iminobiotin as a capturing ligand.
For successful puri¢cation it was essential to use biotin-free
culture medium; if biotin is present in the medium, it will
block the binding sites of avidin/mutants thus hampering sub-
sequent a⁄nity puri¢cation and possible use of the avidin
derivative in applied systems.
3.3. Protein chemical analysis
SDS-PAGE analysis showed that the native avidin and
charge mutants separated into three components (data not
shown), which presumably represented di¡erent stages of
post-translational modi¢cation of glycosylated avidin [16].
There were minor changes in the migration pattern of certain
mutants (especially AvdpI4.7), probably due to the extensive
charge di¡erences. The isoelectric points of the avidin mutants
were determined with isoelectric focusing, using a pH gradient
from 3 to 10 (Fig. 1). The experimental results corresponded
well with the values theoretically calculated from the amino
acid sequences (Table 1). The di¡erences in the case of Avd-
pI9.4 and AvdpI9.0 are probably due to poor resolution in the
upper part of the pH gradient. The experimental value for
avidin could not be determined with this system, since its pI
is over 10, which is out of range of the gel system used in this
study. The quaternary status of the charge mutants, in the
presence and in the absence of biotin, was examined by
FPLC on a Superose 12 column (data not shown). Compar-
ison of the elution pro¢les with molecular mass standards
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Table 1
The physiochemical properties of the avidin charge mutants
Name Mutations pI calculated pI experimental Kd (M)a
Avd None 10.4 n.d. 2.0U1038
AvdpI9.4 R122A, R124A 9.9 9.4 1.4U1037
AvdpI9.0 R26N, R59A 9.3 9.0 3.1U1038
AvdpI7.9 R2A, K3E, K9E 8.1 7.9 2.3U1038
AvdpI7.2 K3E, K9D, R122A, R124A 7.2 7.2 4.5U1037
AvdpI5.9 R2A, K3E, K9E, R122A, R124A 5.9 5.9 3.1U1037
AvdpI4.7 R2A, K3E, K9E, R26N, R59A R122A, R124A 4.7 4.7 3.5U1038
aDissociation constant for 2-iminobiotin at pH 9.5; n.d., not determined.
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showed that all the mutants behaved similarly to native avidin
(56.6 kDa) forming stable tetramers (the molecular masses of
di¡erent mutants varied from 55.3 to 60.5 kDa).
3.4. Biotin-binding characteristics of avidin mutants
All six charge mutants bound strongly to 2-iminobiotin,
since they were e⁄ciently a⁄nity puri¢ed in a single step using
this moiety as a capturing ligand. To further characterize the
biotin-binding a⁄nities of di¡erent mutants, an optical bio-
sensor instrument (IASyS Manual+) was used. When at-
tempts were made to measure the binding constants of mutant
proteins to immobilized biotin, no dissociation was observed
(data not shown). This indicated that all the mutant proteins
exhibited very high a⁄nity constants for biotin ^ similar to
the tenacious binding by the wild-type protein. To obtain
precise information concerning the possible di¡erences in af-
¢nities among the various mutants, 2-iminobiotin was used as
a ligand instead of biotin. Avidin binds 2-iminobiotin at ele-
vated pH with a lower, readily measurable level of a⁄nity.
The analysis of the binding curves of the wild-type avidin and
di¡erent reduced charge mutants, each in several concen-
trations, were used to determine their dissociation constants
to 2-iminobiotin at pH 9.5 (Fig. 2). The calculated Kd =
2.0U1038 M for avidin is in good agreement with that
reported previously by Green [6]. The Kd values for di¡erent
mutants varied from 1.4U1037 M to 3.5U1038 M (Table 1),
suggesting that their biotin-binding properties are quite
similar to that of wild-type avidin.
3.5. Thermal stability of avidin mutants
In order to determine whether the mutations a¡ected the
thermal stability of the avidin tetramer, the avidin mutants
and native avidin were diluted in SDS-containing bu¡er and
heated to temperatures between 25‡C and 100‡C in the ab-
sence and presence of biotin. It has been shown previously
that under the conditions of this assay biotin stabilizes the
quaternary structure of avidin [18]. The transition tempera-
tures for biotin-saturated mutants should therefore be higher
than those of the biotin-free derivatives. Biotin-free native
avidin starts to dissociate into monomers at temperatures
over 57‡C (Fig. 3A), whereas with biotin the transition begins
only at temperatures near 100‡C (Fig. 3B). The results of the
thermostability experiment showed that of all the mutant avi-
dins AvdpI4.7 (Fig. 3C and D) was the most stable. Surpris-
ingly, this mutant appeared to be slightly more stable than
wild-type avidin. AvdpI9.4 and AvdpI9.0 showed dissociation
pro¢les similar to that of native avidin, but biotin-free Avd-
pI7.9, AvdpI7.2 and AvdpI5.9 appeared to dissociate, pre-
sumably into monomers, at room temperatures when SDS
was present (data not shown). Interestingly, in the presence
of biotin they behaved in a manner similar to that of native
avidin, requiring temperatures near 100‡C to dissociate.
3.6. Non-speci¢c binding to DNA
A dot-blot assay was used to investigate the status of the
charge mutations with respect to the non-speci¢c binding
properties of avidin (data not shown). Wild-type avidin bound
strongly to both single- and double-stranded DNA. Most of
this binding seems to be charge-related, since there was a
correlation between lowering the isoelectric point and reduced
binding to DNA; AvdpI4.7 showed the lowest levels of bind-
ing to DNA.
4. Discussion
During the last two decades, avidin has evolved into a key
component in many biotechnological applications such as af-
¢nity-based separations and diagnostic assays [1]. Applica-
tions of avidin-biotin technology utilize the extraordinary af-
¢nity avidin has for biotin. While the usefulness of avidin is
impressive, there are some drawbacks associated with its uti-
lization in some applications. Most of these problems are
related to the high pI of avidin. For example the alkaline
nature of avidin can cause charge-related binding to DNA
and cell surfaces, which may hinder its use in certain circum-
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Fig. 1. Isoelectric focusing of avidin charge mutants. Samples (5 Wg)
of di¡erent charge mutants were applied to polyacrylamide gel with
pH gradient from 3 to 10. Following the run, proteins were visual-
ized by Coomassie brilliant blue staining. Lanes: 1: AvdpI9.4; 2:
AvdpI9.0; 3: AvdpI7.9; 4: AvdpI7.2; 5: AvdpI5.9; 6: AvdpI4.7;
M: pI standard.
Fig. 2. Interaction of native avidin (closed circles) and AvpI4.7
(open circles) with 2-iminobiotin. Various concentrations of avidin
or mutant were added to 2-iminobiotin-coated cuvettes, and binding
was measured in pH 9.5 bu¡er at room temperature using an IASyS
optical biosensor. The equilibrium response (Req) is plotted vs. pro-
tein concentration. The Kd of the protein is equal to the concentra-
tion at Rmax/2.
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stances. The high pI of avidin has also been a detriment to its
use in a⁄nity-based drug targeting, since the positive charge
of avidin is considered to be one of the major reasons for its
rapid removal from the circulation system [3,19^21].
Site-directed mutagenesis is currently the method of choice
to modify properties of a protein or to study the connection
between its structure and function. Successful protein engi-
neering requires understanding of the basic concepts of pro-
tein biosynthesis and structure. In the case of avidin, the
availability of crystallographic data [11,12] together with the
sequence information from avidin-related proteins [10] and
streptavidin [9] have made it possible to design such changes
in an intelligent manner.
In the present work, we wanted to study whether the high
pI of avidin can be reduced without losing its stability or high
a⁄nity for biotin. For this purpose we constructed a set of
reduced charge mutants with isoelectric points ranging from
9.4 down to 4.7. Most of these mutations are based on natural
selection and evolution, since they were designed from se-
quence-based comparison with streptavidin and avidin-related
proteins. Therefore Arg-2 was changed to Ala and Lys-3 to
Glu according to the sequence of streptavidin. Lys-9 was re-
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Fig. 3. Temperature-dependent dissociation of native avidin, AvdpI4.7 and their complexes with biotin. Samples of biotin-free and biotin-satu-
rated avidin or AvdpI4.7 were combined with sample bu¡er and incubated for 20 min at the designated temperatures. The samples were then
subjected to SDS-PAGE in 15% separating gels, and the gels were stained using Coomassie brilliant blue. Note that AvdpI4.7 tetramers (C and
D, thin arrow) penetrated the upper gel, whereas those of the native avidin (A and B, thick arrow) failed to do so. Densitometry tracings from
each of the gels were graphed as a function of temperature: A: avidin; B: avidin+biotin; C: AvdpI4.7; D: AvdpI4.7+biotin.
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placed with Glu according to the sequence of the avidin-re-
lated protein, AVR1. Arg-26 was modi¢ed to Asn according
to AVR1 and AVR2, and Arg-59 to Ala, since alanine ap-
pears at this position in every AVR protein. In AvdpI7.2, Lys-
9 was replaced by Asp instead of Glu due to a PCR error. On
the other hand, Arg-122 and Arg-124 were both altered to
Ala, because these C-terminal residues were not observed in
the crystal structure of avidin [11].
The biotin-binding properties of all charge mutants were
similar to those of native avidin, according to the biosensor
data. The actual a⁄nities for biotin could not be determined,
since it was essentially impossible to remove the bound pro-
teins from the biotin-derivatized cuvette. This was not surpris-
ing, since the current biosensor technology can be used to
determine a⁄nities only up to Ka V1012 M31. We therefore
decided to use 2-iminobiotin as a ligand. Chilkoti et al. [22]
have previously demonstrated 2-iminobiotin to be a good re-
porter for intrinsic streptavidin-biotin interactions and the
same is likely to hold true for avidin. The a⁄nities of mutants
for 2-iminobiotin (Table 1) were comparable to native avidin,
which suggested that their a⁄nities for biotin were also sim-
ilar (Kas probably in the neighborhood of 1013^1015 M31).
This was not so surprising because all the changed amino
acids were on the surface of the protein. In this regard, it
has been shown previously that, at least in the case of lyso-
zyme, the structural changes resulting from mutations of sur-
face residues are smaller and localized near the mutation,
whereas those involving buried residues are larger and may
be transmitted to other parts of the protein [23].
As reported earlier [18], native avidin failed to penetrate the
separating gel during non-denaturing SDS-PAGE and re-
mained in the aggregated state in the stacking gel (Fig. 3A,
arrow). This phenomenon was attributed to the high pI of
avidin and possible strong electrostatic interactions with
SDS. It is thus interesting to note that, under similar non-
denaturing conditions, AvdpI4.7 (Fig. 3C) and most of the
other reduced charge mutants migrated in the separating gel
in a manner consistent with that of a tetramer.
When the thermal stability of the charge mutants was
studied, it was observed that AvdpI9.4, AvdpI9.0 and Avd-
pI4.7 displayed very similar dissociation pro¢les to that of the
wild-type avidin. In contrast, AvdpI7.9, AvdpI7.2 and Avd-
pI5.9 showed some di¡erences. In the absence of biotin, the
latter derivatives tended to dissociate into monomers already
at room temperatures when SDS was present. Interestingly, all
of the mutants were stabilized by the presence of biotin; the
same mutants required temperatures up to 100‡C to undergo
denaturation as does wild-type avidin. AvdpI7.9, AvdpI7.2
and AvdpI5.9 all have mutations on Lys-3 and Lys-9 which
suggests that either of these lysines (or both) could have some
role in the stability of the avidin tetramer. On the other hand,
AvdpI4.7 also bears both of these mutations, yet it seemed to
be even slightly more stable than wild-type avidin. One pos-
sibility is that the additional mutations in AvdpI4.7 (Arg-26
to Asn-26 and Arg-59 to Ala-59) somehow counteract the
e¡ect of mutations on Lys-3/Lys-9. The reasons for this enig-
ma remain to be investigated further.
In summary, we have constructed a progressive series of
reduced charge mutants of the egg-white protein avidin,
with pIs ranging from 9.4 to 4.7. All these mutant proteins
bound biotin very strongly, and their thermostability was, in
most cases, comparable to that of the wild-type avidin. The
mutants also displayed reduced non-speci¢c binding charac-
teristics to DNA when compared to wild-type avidin. Our
results demonstrate that the charge properties of avidin can
be modi¢ed by protein engineering without disturbing the
crucial biotin-binding activity. These modi¢ed avidins (espe-
cially AvdpI4.7) should also prove to be valuable in many
applications of avidin-biotin technology, including a⁄nity-
based drug targeting and di¡erent separation technologies.
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